Trials / Completed
CompletedNCT00319189
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (planned)
- Sponsor
- University of Oslo School of Pharmacy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the present study is to evaluate both the efficacy and safet of nateglinide in renal transplanta recipients with posttransplant diabetes mellitus or impaired glucose tolerance. Primarily will the change in glucose tolerance and acute insuline responce be addressed.
Conditions
- Renal Transplant Recipients
- Posttransplant Diabetes Mellitus
- Posttransplant Impaired Glucose Tolerance
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nateglinide |
Timeline
- Start date
- 2002-11-01
- Completion
- 2003-11-01
- First posted
- 2006-04-27
- Last updated
- 2006-05-10
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00319189. Inclusion in this directory is not an endorsement.